HOWL Insider Transactions — Page 2
587 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Kolchinsky Peter | TenPercentOwner | 2026-05-08 | Sale | 351,514.0 | $0.71 |
| Shah Rajeev M. | TenPercentOwner | 2026-05-08 | Sale | 351,514.0 | $0.71 |
| EVNIN LUKE | Director | 2026-05-08 | Sale | 305,741.0 | $0.7 |
| EVNIN LUKE | Director | 2026-05-07 | Sale | 79,086.0 | $0.63 |
| EVNIN LUKE | Director | 2026-05-06 | Sale | 14,635.0 | $0.66 |
| EVNIN LUKE | Director | 2026-05-05 | Sale | 6,860.0 | $0.69 |
| EVNIN LUKE | Director | 2026-05-04 | Sale | 47,963.0 | $0.72 |
| EVNIN LUKE | Director | 2026-05-01 | Sale | 58,394.0 | $0.73 |
| EVNIN LUKE | Director | 2026-04-30 | Sale | 168,262.0 | $0.72 |
| EVNIN LUKE | Director | 2026-04-29 | Sale | 56,559.0 | $0.69 |
| EVNIN LUKE | Director | 2026-04-28 | Sale | 95,412.0 | $0.73 |
| EVNIN LUKE | Director | 2026-04-27 | Sale | 53,940.0 | $0.85 |
| EVNIN LUKE | Director | 2026-01-16 | Sale | 38,782.0 | $0.54 |
| EVNIN LUKE | Director | 2026-01-15 | Sale | 37,413.0 | $0.55 |
| EVNIN LUKE | Director | 2026-01-14 | Sale | 30,616.0 | $0.57 |
| EVNIN LUKE | Director | 2026-01-13 | Sale | 43,198.0 | $0.55 |
| EVNIN LUKE | Director | 2026-01-12 | Sale | 58,980.0 | $0.57 |
| EVNIN LUKE | Director | 2026-01-09 | Sale | 24,678.0 | $0.61 |
| EVNIN LUKE | Director | 2026-01-08 | Sale | 7,716.0 | $0.63 |
| EVNIN LUKE | Director | 2026-01-07 | Sale | 11,915.0 | $0.64 |
| EVNIN LUKE | Director | 2026-01-06 | Sale | 40,761.0 | $0.65 |
| EVNIN LUKE | Director | 2026-01-05 | Sale | 18,378.0 | $0.64 |
| EVNIN LUKE | Director | 2026-01-02 | Sale | 18,568.0 | $0.63 |
| EVNIN LUKE | Director | 2025-12-31 | Sale | 24,962.0 | $0.62 |
| EVNIN LUKE | Director | 2025-12-30 | Sale | 34,847.0 | $0.61 |
| EVNIN LUKE | Director | 2025-12-29 | Sale | 108,606.0 | $0.61 |
| EVNIN LUKE | Director | 2025-12-26 | Sale | 35,632.0 | $0.63 |
| EVNIN LUKE | Director | 2025-12-24 | Sale | 16,310.0 | $0.65 |
| EVNIN LUKE | Director | 2025-12-23 | Sale | 71,428.0 | $0.63 |
| EVNIN LUKE | Director | 2025-12-22 | Sale | 59,307.0 | $0.69 |
| EVNIN LUKE | Director | 2025-12-17 | Sale | 9,983.0 | $1.14 |
| EVNIN LUKE | Director | 2025-12-16 | Sale | 14,548.0 | $1.05 |
| EVNIN LUKE | Director | 2025-12-15 | Sale | 23,640.0 | $1.07 |
| EVNIN LUKE | Director | 2025-12-12 | Sale | 17,858.0 | $1.08 |
| EVNIN LUKE | Director | 2025-12-11 | Sale | 28,009.0 | $1.07 |
| EVNIN LUKE | Director | 2025-12-10 | Sale | 37,104.0 | $1.06 |
| EVNIN LUKE | Director | 2025-12-09 | Sale | 44,570.0 | $1.01 |
| EVNIN LUKE | Director | 2025-12-08 | Sale | 34,041.0 | $0.99 |
| EVNIN LUKE | Director | 2025-12-05 | Sale | 16,568.0 | $0.97 |
| MPM BioVentures 2014, L.P. | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM BioVentures 2014 (B), L.P. | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM Asset Management Investors BV2014 LLC | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM BioVentures 2014 LLC | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM BioVentures 2014 GP LLC | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| GADICKE ANSBERT | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM ASSET MANAGEMENT LLC | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM BioImpact LLC | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| UBS Oncology Impact Fund L.P. | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM ONCOLOGY INNOVATIONS FUND LP | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| Oncology Impact Fund (Cayman) Management L.P. | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| MPM Oncology Innovations Fund GP LLC | Other | 2025-12-04 | Sale | 83,230.0 | $0.97 |
| EVNIN LUKE | Director | 2025-12-04 | Sale | 53,416.0 | $0.97 |
| MPM BioVentures 2014, L.P. | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM BioVentures 2014 (B), L.P. | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM Asset Management Investors BV2014 LLC | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM BioVentures 2014 LLC | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM BioVentures 2014 GP LLC | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| GADICKE ANSBERT | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM ASSET MANAGEMENT LLC | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM BioImpact LLC | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| UBS Oncology Impact Fund L.P. | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM ONCOLOGY INNOVATIONS FUND LP | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| Oncology Impact Fund (Cayman) Management L.P. | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| MPM Oncology Innovations Fund GP LLC | Other | 2025-12-03 | Sale | 57,225.0 | $0.87 |
| EVNIN LUKE | Director | 2025-12-03 | Sale | 36,726.0 | $0.87 |
| MPM BioVentures 2014, L.P. | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM BioVentures 2014 (B), L.P. | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM Asset Management Investors BV2014 LLC | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM BioVentures 2014 LLC | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM BioVentures 2014 GP LLC | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| GADICKE ANSBERT | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM ASSET MANAGEMENT LLC | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM BioImpact LLC | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| UBS Oncology Impact Fund L.P. | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM ONCOLOGY INNOVATIONS FUND LP | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| Oncology Impact Fund (Cayman) Management L.P. | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| MPM Oncology Innovations Fund GP LLC | Other | 2025-12-02 | Sale | 59,277.0 | $0.89 |
| EVNIN LUKE | Director | 2025-12-02 | Sale | 38,043.0 | $0.89 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| GADICKE ANSBERT | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM BioImpact LLC | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-12-01 | Sale | 60,917.0 | $0.94 |
| EVNIN LUKE | Director | 2025-12-01 | Sale | 39,096.0 | $0.94 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |